Invention Grant
US08193230B2 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
有权
包含N 3烷基化苯并咪唑衍生物作为MEK抑制剂的组合物及其使用方法
- Patent Title: Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
- Patent Title (中): 包含N 3烷基化苯并咪唑衍生物作为MEK抑制剂的组合物及其使用方法
-
Application No.: US12824547Application Date: 2010-06-28
-
Publication No.: US08193230B2Publication Date: 2012-06-05
- Inventor: Eli M. Wallace , Joseph P. Lyssikatos , Allison L. Marlow , T. Brian Hurley
- Applicant: Eli M. Wallace , Joseph P. Lyssikatos , Allison L. Marlow , T. Brian Hurley
- Applicant Address: US CO Boulder
- Assignee: Array Biopharma Inc.
- Current Assignee: Array Biopharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Viksins Harris & Padys PLLP
- Agent John R. Moore, Esq.; Sarah S. Mastous
- Main IPC: A61K31/4184
- IPC: A61K31/4184
Abstract:
Disclosed are pharmaceutical compositions comprising 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide, or a pharmaceutically acceptable salt thereof. Also disclosed are methods of using such compositions for inhibiting abnormal cell growth or treating hyperproliferative diseases in mammals.
Public/Granted literature
Information query
IPC分类:
